NASDAQ
Impact BioMedical Inc. (IBO) has a free cash flow growth of -568.69% as of Friday, May 29, 2026. This represents a 96.77% increase compared to its 12-month average of -17604.09%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.